<DOC>
	<DOC>NCT00849732</DOC>
	<brief_summary>This three stage study will evaluate the safety and tolerability of MRKAd5 HIV-1 Gag Vaccine. In Stage I subjects will be randomized to receive the vaccine at 1x10^9 viral particles/dose (vp/d) or placebo. In Stage II subjects will be randomized to receive the vaccine at 1x10^10 vp/d or placebo. In Stage III subjects will be randomized to receive the vaccine at 1x10^9 vp/d, at 1x10^10 vp/d, or placebo. Immunogenicity of the single dose regimen of MRKAd5 HIV-1 Gag Vaccine will also be measured.</brief_summary>
	<brief_title>A Worldwide, Phase I, Dose-Escalating Study of a 3-Dose Regimen of the MRKAd5 (Clade B) Vaccine in Healthy Adults (V520-018)</brief_title>
	<detailed_description />
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Subject is in good general health Subject tests negative for Hepatitis B, Hepatitis C, and HIV Subjects of reproductive potential agree to use an accepted method of birth control through the entire study Subject has a recent history of fever at time of vaccination Subject has received immune globulin or blood product 3 months prior to injection Subject has been vaccinated with live virus vaccine 30 days prior to receipt of first dose Subject has been vaccinated with inactivated vaccine with 14 days prior to receipt of first dose Subject has a chronic medical condition that is considered progressive Subject has history of malignancy Subject weighs less than 105 lb. Female subject is pregnant or breast feeding, Male subject is planning to impregnate during the first year of study Subject has contraindication to intramuscular injection Subject is unlikely or unwilling to adhere to lower risk sex practices during the course of the study Subject has a tattoo on the deltoid region of the arm or the injection of DepoProvera</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>February 2015</verification_date>
	<keyword>HIV Seronegativity</keyword>
	<keyword>Preventive Vaccine</keyword>
</DOC>